Adaptin Bio Cash Flow Statement (2023-2026) | APTN

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M
Share-based Compensation (Quarter) 0.32M0.25M0.35M
Gains from Investment Securities (Quarter) 133.000.00M0.01M0.01M0.01M1.43M
Cash from Operations (Quarter) -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.03M0.02M0.08M0.11M0.05M
Change in Working Capital
Change in Account Payables (Quarter) 0.00M0.00M0.28M-0.07M0.44M0.43M-0.69M0.34M0.67M0.17M-0.14M
Change in Accured Expenses (Quarter) -0.03M-0.07M0.10M0.62M0.20M0.02M-0.55M0.54M-0.47M0.26M
Other Working Capital Changes (Quarter) -0.24M
Financing Activities
Other financing activities (Quarter) 6.16M1.00M
Cash from Financing Activities (Quarter) 0.06M0.09M0.22M0.56M-0.19M4.62M0.58M0.44M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 6.16M0.65M
Additional items
Change in Cash (Quarter) 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M
Free Cash Flow (Quarter) -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M
Net Cash Flow (Quarter) 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M